Plagnol, AC and Rowley, E and Martin, P and Livesey, F (2009) Industry perceptions of barriers to commercialization of regenerative medicine products in the UK. Regen Med, 4. pp. 549-559.Full text not available from this repository.
Regenerative medicine is an emerging field with the potential to provide widespread improvement in healthcare and patient wellbeing via the delivery of therapies that can restore, regenerate or repair damaged tissue. As an industry, it could significantly contribute to economic growth if products are successfully commercialized. However, to date, relatively few products have reached the market owing to a variety of barriers, including a lack of funding and regulatory hurdles. The present study analyzes industry perceptions of the barriers to commercialization that currently impede the success of the regenerative medicine industry in the UK.
|Uncontrolled Keywords:||Commerce Great Britain Interviews as Topic Regenerative Medicine|
|Divisions:||Div E > Strategy and Policy|
Div E > Economics and Policy
|Depositing User:||Cron Job|
|Date Deposited:||07 Mar 2014 11:22|
|Last Modified:||17 Nov 2014 01:07|